跳至主要内容
临床试验/NCT06610500
NCT06610500已完成不适用

Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry

Centre Hospitalier Universitaire de Saint Etienne1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年5月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Rate of non-compliance

研究概览

简要总结

Clozapine is a drug that requires regular and diligent hematological monitoring throughout its use. This follow-up is, in France, framed by a compulsory paper format of the blood count follow-up notebook for each patient. Due to the multiplicity of the different modes of transmission of the different documents necessary for compliance with the regulations for the prescription, dispensing and administration of clozapine, we decided to carry out a current inventory in the department of Loire with respect for the latter. The main objective of this study is to assess the rate of non-compliance in circuits of prescription, dispensing and administration of clozapine by sending a questionnaire on habits of prescriptions, dispensing and administration of health professionals (psychiatrists, pharmacists), and by sending a questionnaire to the patients treated by clozapine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Population 1: all patients stabilized of Medical-Psychological Center (CMP) of St-Etienne treated with clozapine
  • Population 2 : all psychiatrists of the Loire department
  • Population 2 : all pharmacists of the Loire department

排除标准

  • 未提供

结局指标

主要结局

Rate of non-compliance

时间窗: Month: 2

Rate of non-compliance in the circuits for prescribing, dispensing clozapine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验